Gene · 10036
Papers2,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CAF-1 in Replication and Repair: A Critical Genetic Mediator of Synthesis-Coupled Nucleosome Assembly. | Biomolecules | 2026 | 42793109 | PubTator, text mining | PubMed |
| FACT-(H3-H4) complex stimulates Pol α activity to coordinate DNA synthesis with nucleosome assembly. | Sci Adv | 2026 | 42789711 | PubTator, text mining | PubMed |
| Integrative proteomics reveals MSH6 to modulate PARP inhibitor sensitivity in BRCA1/2-proficient ovarian cancer. | PLoS One | 2026 | 42685115 | PubTator, text mining | PubMed |
| Receptor specificity and translational considerations for laminin-mimetic Caf1 scaffolds: reply from authors. | Br J Dermatol | 2026 | 42574656 | PubTator, text mining | PubMed |
| CHAF1A promotes RAD51 loading and homologous recombination to drive tumor radioresistance. | Oncogene | 2026 | 42552448 | PubTator, text mining | PubMed |
| CHAF1A identified as a candidate biomarker and potential therapeutic target in Burkitt lymphoma through integrated bioinformatics and histopathological analysis. | Hematology | 2026 | 42535765 | PubTator, text mining | PubMed |
| Chaf1a is required for cardiomyocyte karyokinesis and cardiac endowment. | Protein Cell | 2026 | 42500988 | PubTator, text mining | PubMed |
| The role of electrostatic interactions in the phase separation of HP1α and its protein binding partners. | bioRxiv | 2026 | 42465301 | PubTator, text mining | PubMed |
| Elevated CHAF1A Suppresses Type I Interferon Production and Causes Immunotherapy Resistance in Esophageal Squamous Cell Carcinoma. | Cancer Immunol Res | 2026 | 42462139 | PubTator, text mining | PubMed |
| Targeting ADAR1 p150 triggers tumor inhibition and antitumor immunity to overcome immunotherapy resistance. | iScience | 2026 | 42221825 | PubTator, text mining | PubMed |
| Uncovering the role of the PPR protein PHOTOSYSTEM ONE BIOGENESIS FACTOR6 in splicing chloroplast group II introns. | J Integr Plant Biol | 2026 | 42135903 | PubTator, text mining | PubMed |
| NAT10/ac4C drives intrahepatic cholangiocarcinoma by suppressing transposable elements via chromatin remodeling. | Proc Natl Acad Sci U S A | 2026 | 42133812 | PubTator, text mining | PubMed |
| NANOG Proximity Proteomics Maps Neighborhood Hubs Linked to Mesenchymal Stem Cell Stemness and Chromatin Control. | Biomolecules | 2026 | 42072652 | PubTator, text mining | PubMed |
| TONSOKU prevents the formation of large tandem duplications and restrains ATR-WEE1 checkpoint activation. | Nat Commun | 2026 | 41896247 | PubTator, text mining | PubMed |
| Epigenetic Activity of Cancer Therapy Drugs Revealed by HeLa TI Cell-Based Assay. | Epigenomes | 2026 | 41892363 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screens identify the EXO1-CAF-1 pathway suppressing R-loop-associated DNA damage. | Nucleic Acids Res | 2026 | 41841497 | PubTator, text mining | PubMed |
| A de novo H3.2K9me2 deposition pathway establishes heterochromatin for suppressing transposon mobilization during fly somatic development. | Nucleic Acids Res | 2026 | 41755642 | PubTator, text mining | PubMed |
| TRKB-based signature identifies high-risk squamous cell carcinoma cases and TRKB blockade reprograms tumor and stromal cells toward suppressive phenotypes. | J Biomed Sci | 2026 | 41742188 | PubTator, text mining | PubMed |
| Analysis of EGFR signaling pathway; miRNAs and inflammatory biomarkers in a high-risk oral cancer population in Pakistan - An exploratory study. | PLoS One | 2026 | 41729911 | PubTator, text mining | PubMed |
| A toolkit for programmable transcriptional engineering across eukaryotic kingdoms. | bioRxiv | 2026 | 41726944 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10036/papers